| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenues | 65,625 | 53,400 | NaN | 31,500 |
| Product costs | 44,337 | 35,478 | NaN | 22,050 |
| Total cost of goods sold | 44,337 | 35,478 | NaN | 22,050 |
| Gross margin | 21,288 | 17,922 | NaN | 9,450 |
| General and administrative | 836,187 | 1,171,137 | 1,439,552 | 1,943,127 |
| Research and development | 203,444 | 479,657 | 2,769,236 | 326,361 |
| Total costs and expenses | 1,039,631 | 1,650,794 | 4,208,788 | 2,269,487 |
| Loss from operations | -1,018,343 | -1,632,872 | -4,208,788 | -2,260,037 |
| Interest expense | 12,959 | 7,360 | 2,400 | 8,560 |
| Amortization of debt discount | NaN | 0 | NaN | NaN |
| Other expense | 1,754 | 7,360 | 2,400 | 8,560 |
| Total other expense | -14,713 | NaN | NaN | NaN |
| Net loss | -1,033,056 | -1,640,232 | -4,211,188 | -2,268,597 |
| Diluted EPS | -0.27 | -0.43 | -1.12 | NaN |
| Diluted Average Shares | 3,817,172 | 3,810,065 | 3,750,079 | NaN |
Zivo Bioscience, Inc. (ZIVO)
Zivo Bioscience, Inc. (ZIVO)